Inhibition of transforming growth factor β production by nitric oxide- treated chondrocytes

Arthritis and Rheumatism

Volumn 42, Issue 2, 1999, Pages 248-257

  Studer, R K ^a   Georgescu, H I ^a   Miller, L A ^a   Evans, C H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1BETA; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING KINETICS; CARTILAGE CELL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; RABBIT;

ANIMALS; ARGININE; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; INTERLEUKIN-1; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PENICILLAMINE; PROTEOGLYCANS; RABBITS; S-NITROSO-N-ACETYLPENICILLAMINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032968296     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199902)42:2<248::AID-ANR6>3.0.CO;2-S     Document Type: Article

References (43)

1. Evans CH, Watkins SC, Stefanovic-Racic M. Nitric oxide and cartilage metabolism. Methods Enzymol 1996;269:75-88.
2. Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villager PM, et al. Cytokine regulation of chondrocyte function. J Rheumatol 1995;22 Suppl 43:104-8.
3. Van Beuningen JM, van der Kraan PM, Arntz OJ, van den Berg VM. Protection from interleukin-1 induced destruction of articular cartilage by transforming growth factor β: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 1993;52:185-91.
4. Van Beuningen JM, van der Kraan PM, Arntz OJ, van den Berg VM. Transforming growth factor-β1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-90.
5. Morales TI. Transforming growth factor-β and insulin-like growth factor-1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid. Arch Biochem Biophys 1994;315:190-8.
6. Lum ZP, Hakala BE, Mort JS, Recklies AD. Modulation of the catabolic effects of interleukin-1β on human articular chondrocytes by transforming growth factor-β. J Cell Physiol 1996;166: 351-9.
7. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Gcorgescu HI, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-20.
8. Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993;193:398-405.
9. Maier R, Bilbe G, Rediske J, Lotz M. Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim Biophys Acta 1994;1208: 145-50.
10. Taskiran D, Stefanovic-Racic M, Georgescu HI, Evans CH. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-8.
11. Stefanovic-Racic M, Mollers MO, Miller LA, Evans CH. Nitric oxide and proteoglycan turnover in rabbit articular cartilage. J Orthop Res 1997;15:442-9.
12. Jaravinen TAH, Moilanen T, Jarvinen LLN, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage [abstract]. Med Inflamm 1995;4:107-11.
13. Hickery MS, Palmer RMJ, Charles IG, Moncada S, Bayliss MT. The role of nitric oxide in IL-1- and TNF-α-induced inhibition of proteoglycan synthesis in human articular cartilage. Trans Orthop Res Soc 1994;19:77.
14. Hauselmann HJ, Oppliger L, Michel BA, Stefanovic-Racic M, Evans CH. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 1994;352: 361-4.
15. Fukuda K, Kumano F, Takayama M, Saito M, Otani K, Tanake S. Zonal differences in nitric oxide synthesis by bovine chondrocytes exposed to interleukin-1. Inflamm Res 1995;44:434-7.
16. Stefanovic-Racic M, Morales T, Taskiran D, McIntyre LA, Evans CH. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ culture. J Immunol 1996;156:1213-20.
17. Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, et al. Nitric oxide inhibits the synthesis of type II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997;324:305-10.
18. Studer RK, DeRubertis FR, Craven PA. Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor β, and fibronectin synthesis induced by thromboxane. J Am Soc Nephrol 1996;7:999-1006.
19. Craven PA, Studer RK, Felder J, Phillips S, DeRubertis FR. Nitric oxide inhibition of transforming growth factor-β and collagen synthesis in mesangial cells. Diabetes 1997;46:671-81.
20. Vodovotz Y, Bogdan C, Paik J, Xie Q-W, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β. J Exp Med 1993;178:605-13.
21. Vodovotz Y, Bogdan C. Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. Prog Growth Factor Res 1994;5:341-51.
22. Perella MA, Patterson C, Tan L, Yet S-F, Hsieh C-M, Yoshizumi M, et al. Suppression of interleukin-1β-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-β1 in vascular smooth muscle cells. J Biol Chem 1996;271: 13776-80.
23. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 1994;21:1892-8.
24. Blanco RJ, Gens Y, Lotz M. Differentiation dependent effects of IL-1 and TGFβ on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J Immunol 1995;154:4018-26.
25. Green WT. Behavior of articular chondrocytes in cell culture. Clin Orthop 1971;75:248-60.
26. 15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
27. Studer RK, Negrete H, Craven PA, DeRubertis FR. Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-β bioactivity in mesangial cells. Kidney Int 1995;48:422-30.
28. Danielpour K, Dart LL, Flanders KC, Roberts AB, Sporn MB. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol 1989;138:79-86.
29. Villiger PM, Kusari AB, ten Dijke P, Lotz M. IL-1β and IL-6 selectively induce transforming growth factor-β isoforms in human articular chondrocytes. J Immunol 1993;151:3337-44.
30. Kim S-J, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB. Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 1989;264: 19373-8.
31. Roberts AB, Kim S-J, Noma T, Glick AB, Lafyatis R, Lechleider R, et al. Multiple forms of TGF-β: distinct promoters and differential expression. Ciba Found Symp 1991;157:7-28.
32. 3. J Biol Chem 1994;269: 28374-81.
33. Villiger PM, Lotz M. Differential expression of TGF-β isoforms by human articular chondrocytes in response to growth factors. J Cell Physiol 1992;151:318-25.
34. Tabuchi A, Oh E, Taoka A, Sakurai H, Tsuchiya T, Tsuda M. Rapid attenuation of AP-1 transcriptional factor associated with nitric oxide (NO)-mediated neuronal cell death. J Biol Chem 1996;271:31061-7.
35. Tabuchi A, Sano K, Oh E, Tsuchiya T, Tsuda M. Modulation of AP-1 activity by nitric oxide (NO) in vitro: NO mediated modulation of AP-1. FEBS Lett 1994;351:123-7.
36. Lin CW, Robbins PD, Georgescu HI, Evans CH. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts. Exp Cell Res 1996;223:117-26.
37. Flaumenhaft R, Kojima S, Abe M, Rifkin DB. Activation of latent transforming growth factor β. Adv Pharmacol 1993;124:51-73.
38. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide and energy production in articular chondrocytes. J Cell Physiol 1995;:159:274-80.
39. Barcellos-Hoff NM, Dix TA. Redox-mediated activation of latent transforming growth factor-β1. Mol Endocrinol 1996;10:1077-83.
40. Fukuda K, Takayama M, Ueno M, Oh S, Asada F, Kumano F, et al. Hyaluronic acid inhibits interleukin-1-induced superoxide anion in bovine chondrocytes. Inflamm Res 1997;46:114-17.
41. Morales TI, Roberts AB. The interaction between retinoic acid and the transforming growth factors-β in calf articular cartilage organ cultures. Arch Biochem Biophys 1992;293:79-84.
42. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
43. Wahl SM. Transforming growth factor β: the good, the bad, and the ugly. J Exp Med 1994;180:1587-90.